Literature DB >> 1614239

Respiratory infections and asthma.

U S Björnsdottir1, W W Busse.   

Abstract

Airway responsiveness is increased during respiratory virus infections, both in subjects with asthma and without underlying pulmonary disease. Furthermore, the airway hyperresponsiveness is altered for a prolonged period of time, weeks or months after the viral illness has subsided. This article reviews the possible mechanisms of virus-associated airway hyperresponsiveness, including the complex interplay of IgE-dependent reactions, changes in autonomic nervous system function and inflammation, epithelial damage, effects of viruses on the cellular immune response, and enhanced late-phase response.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1614239     DOI: 10.1016/s0025-7125(16)30331-5

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  5 in total

1.  Sino-bronchial syndrome in children with asthma.

Authors:  S Rajajee; S Geetha; S Janani
Journal:  Indian J Pediatr       Date:  1996 Jul-Aug       Impact factor: 1.967

2.  Parainfluenza virus type-3 infection attenuates the respiratory effects of antigen challenge in sensitized guinea pigs.

Authors:  E M Kudlacz; R W Knippenberg
Journal:  Inflamm Res       Date:  1995-03       Impact factor: 4.575

3.  Mechanism of rhinovirus-induced changes in airway smooth muscle responsiveness.

Authors:  H Hakonarson; N Maskeri; C Carter; R L Hodinka; D Campbell; M M Grunstein
Journal:  J Clin Invest       Date:  1998-11-01       Impact factor: 14.808

4.  ETB but not ETA receptor-mediated contractions to endothelin-1 attenuated by respiratory tract viral infection in mouse airways.

Authors:  P J Henry; R G Goldie
Journal:  Br J Pharmacol       Date:  1994-08       Impact factor: 8.739

5.  Interleukin-11: stimulation in vivo and in vitro by respiratory viruses and induction of airways hyperresponsiveness.

Authors:  O Einarsson; G P Geba; Z Zhu; M Landry; J A Elias
Journal:  J Clin Invest       Date:  1996-02-15       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.